XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF NONCONTROLLING INTEREST, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Previously Reported
Legacy Gelesis Redeemable Convertible Preferred Stock
Legacy Gelesis Redeemable Convertible Preferred Stock
Previously Reported
Legacy Gelesis Redeemable Convertible Preferred Stock
Retroactive Application of Recapitalization
Series A-3 Redeemable Convertible Preferred Stock
Common Stock Commitment Shares
Noncontrolling Interest
Noncontrolling Interest
Previously Reported
Common Stock
Common Stock
Previously Reported
Common Stock
Retroactive Application of Recapitalization
Common Stock
Common Stock Commitment Shares
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Common Stock Commitment Shares
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive (Loss) Income
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Balance at Dec. 31, 2020 $ (146,938) $ (146,938)               $ 1 $ 1     $ 23,907 $ 23,907   $ 938 $ 938 $ (171,784) $ (171,784)
Temporary Equity Balance at Dec. 31, 2020     $ 213,525 $ 213,525       $ 12,429 $ 12,429                      
Temporary Equity Balance, shares at Dec. 31, 2020     47,813,946 18,446,525 29,367,421                              
Balance, shares at Dec. 31, 2020                   5,587,094 2,155,490 3,431,604                
Accretion of Legacy Gelesis senior preferred stock to redemption value (33,761)                         (33,761)            
Temporary Equity, Accretion of Legacy Gelesis senior preferred stock to redemption value     $ 33,761                                  
Temporary Equity, Exercise of Legacy Gelesis preferred stock warrants           $ 2,997                            
Temporary Equity, Exercise of Legacy Gelesis preferred stock warrants, shares           752,709                            
Stock based compensation expense 1,455                         1,455            
Issuance of common stock upon exercise of stock options 4                         4            
Issuance of common stock upon exercise of stock options shares                   2,634                    
Accretion of noncontrolling interest put option to redemption value (94)                                   (94)  
Temporary Equity, Accretion of noncontrolling interest put option to redemption value               94                        
Foreign currency translation adjustment (411)                               (411)      
Temporary Equity, Foreign currency translation adjustment               (546)                        
Net loss (18,586)                                   (18,586)  
Balance at Mar. 31, 2021 (198,331)                 $ 1       (8,395)     527   (190,464)  
Temporary Equity Balance at Mar. 31, 2021       $ 250,283       11,977                        
Temporary Equity Balance, shares at Mar. 31, 2021     48,566,655                                  
Balance, shares at Mar. 31, 2021                   5,589,728                    
Balance at Dec. 31, 2020 (146,938) (146,938)               $ 1 $ 1     23,907 23,907   938 938 (171,784) (171,784)
Temporary Equity Balance at Dec. 31, 2020     $ 213,525 $ 213,525       12,429 12,429                      
Temporary Equity Balance, shares at Dec. 31, 2020     47,813,946 18,446,525 29,367,421                              
Balance, shares at Dec. 31, 2020                   5,587,094 2,155,490 3,431,604                
Net loss (74,055)                                      
Balance at Sep. 30, 2021 (356,892)                 $ 1       (111,141)     372   (246,124)  
Temporary Equity Balance at Sep. 30, 2021     $ 356,696         12,021                        
Temporary Equity Balance, shares at Sep. 30, 2021     48,566,655                                  
Balance, shares at Sep. 30, 2021                   5,615,192                    
Balance at Mar. 31, 2021 (198,331)                 $ 1       (8,395)     527   (190,464)  
Temporary Equity Balance at Mar. 31, 2021       $ 250,283       11,977                        
Temporary Equity Balance, shares at Mar. 31, 2021     48,566,655                                  
Balance, shares at Mar. 31, 2021                   5,589,728                    
Accretion of Legacy Gelesis senior preferred stock to redemption value (82,365)                         (82,365)            
Temporary Equity, Accretion of Legacy Gelesis senior preferred stock to redemption value     $ 82,365                                  
Temporary Equity, Exercise of Legacy Gelesis preferred stock warrants     $ 937                                  
Stock based compensation expense 1,639                         1,639            
Issuance of common stock upon exercise of stock options 5                         5            
Issuance of common stock upon exercise of stock options shares                   25,464                    
Accretion of noncontrolling interest put option to redemption value (96)                                   (96)  
Temporary Equity, Accretion of noncontrolling interest put option to redemption value               96                        
Foreign currency translation adjustment 43                               43      
Temporary Equity, Foreign currency translation adjustment               152                        
Net loss (24,739)                                   (24,739)  
Balance at Jun. 30, 2021 (303,844)                 $ 1       (89,116)     570   (215,299)  
Temporary Equity Balance at Jun. 30, 2021       333,585       12,225                        
Temporary Equity Balance, shares at Jun. 30, 2021     48,566,655                                  
Balance, shares at Jun. 30, 2021                   5,615,192                    
Accretion of Legacy Gelesis senior preferred stock to redemption value (23,111)                         (23,111)            
Temporary Equity, Accretion of Legacy Gelesis senior preferred stock to redemption value     $ 23,111                                  
Stock based compensation expense 1,086                         1,086            
Accretion of noncontrolling interest put option to redemption value (95)                                   (95)  
Temporary Equity, Accretion of noncontrolling interest put option to redemption value               95                        
Foreign currency translation adjustment (198)                               (198)      
Temporary Equity, Foreign currency translation adjustment               (299)                        
Net loss (30,730)                                   (30,730)  
Balance at Sep. 30, 2021 (356,892)                 $ 1       (111,141)     372   (246,124)  
Temporary Equity Balance at Sep. 30, 2021     $ 356,696         12,021                        
Temporary Equity Balance, shares at Sep. 30, 2021     48,566,655                                  
Balance, shares at Sep. 30, 2021                   5,615,192                    
Balance at Dec. 31, 2021 (329,836) (329,836)               $ 1 $ 1     (64,549) (64,549)   219 219 (265,507) (265,507)
Temporary Equity Balance at Dec. 31, 2021     $ 311,594 $ 311,594       11,855 11,855                      
Temporary Equity Balance, shares at Dec. 31, 2021     48,566,655 18,736,936 29,829,719                              
Balance, shares at Dec. 31, 2021                   6,248,192 2,410,552 3,837,640                
Accretion of legacy gelesis senior preferred stock to redemption value prior to business combination (37,934)                         (37,934)            
Temporary Equity, Accretion of legacy gelesis senior preferred stock to redemption value prior to business combination     $ 37,934                                  
Conversion of legacy gelesis convertible preferred stock into common stock upon business combination 349,528                         349,528            
Conversion of legacy gelesis convertible preferred stock into common stock upon business combination, shares                   48,566,655                    
Temporary Equity, Conversion of legacy gelesis convertible preferred stock into common stock upon business combination     $ (349,528)                                  
Temporary Equity, Conversion of legacy gelesis convertible preferred stock into common stock upon business combination, shares     (48,566,655)                                  
Proceeds from business combination, net of issuance costs and assumed liabilities 70,478                 $ 6       70,472            
Proceeds from business combination, net of issuance costs and assumed liabilities, shares                   17,399,440                    
Conversion of legacy gelesis preferred stock warrants into common stock warrants upon business combination 16,747                         16,747            
Recognition of earnout liability upon Business Combination (58,871)                         (58,871)            
Assumed private placement warrant liability upon business combination (8,140)                         (8,140)            
Exercise of warrants 4                         4            
Exercise of warrants, shares                   176,126                    
Stock based compensation expense 13,989                         13,989            
Accretion of noncontrolling interest put option to redemption value (88)                                   (88)  
Temporary Equity, Accretion of noncontrolling interest put option to redemption value               88                        
Foreign currency translation adjustment (137)                               (137)      
Temporary Equity, Foreign currency translation adjustment               (239)                        
Net loss (5,703)                                   (5,703)  
Balance at Mar. 31, 2022 10,037                 $ 7       281,246     82   (271,298)  
Temporary Equity Balance at Mar. 31, 2022               11,704                        
Balance, shares at Mar. 31, 2022                   72,390,413                    
Balance at Dec. 31, 2021 $ (329,836) $ (329,836)               $ 1 $ 1     (64,549) $ (64,549)   219 $ 219 (265,507) $ (265,507)
Temporary Equity Balance at Dec. 31, 2021     $ 311,594 $ 311,594       11,855 $ 11,855                      
Temporary Equity Balance, shares at Dec. 31, 2021     48,566,655 18,736,936 29,829,719                              
Balance, shares at Dec. 31, 2021                   6,248,192 2,410,552 3,837,640                
Issuance of common stock upon exercise of stock options shares 162,064                                      
Net loss $ (32,365)                                      
Balance at Sep. 30, 2022 (3,595)                 $ 7       295,333     (810)   (298,125)  
Temporary Equity Balance at Sep. 30, 2022               10,474                        
Temporary Equity Balance, shares at Sep. 30, 2022     0                                  
Balance, shares at Sep. 30, 2022                   72,983,488                    
Balance at Mar. 31, 2022 10,037                 $ 7       281,246     82   (271,298)  
Temporary Equity Balance at Mar. 31, 2022               11,704                        
Balance, shares at Mar. 31, 2022                   72,390,413                    
Stock based compensation expense 7,976                         7,976            
Issuance of common stock upon exercise of stock options 110                         110            
Issuance of common stock upon exercise of stock options shares                   162,064                    
Accretion of noncontrolling interest put option to redemption value (85)                                   (85)  
Temporary Equity, Accretion of noncontrolling interest put option to redemption value               85                        
Foreign currency translation adjustment (426)                               (426)      
Temporary Equity, Foreign currency translation adjustment               (702)                        
Net loss (12,513)                                   (12,513)  
Balance at Jun. 30, 2022 5,099                 $ 7       289,332     (344)   (283,896)  
Temporary Equity Balance at Jun. 30, 2022               11,087                        
Balance, shares at Jun. 30, 2022                   72,552,477                    
Stock based compensation expense 4,574                         4,574            
Release of restricted stock units, shares                   41,404                    
Issuance of common stock             $ 500                 $ 500        
Issuance of common stock, shares                         355,361              
Sale of common stock, net of commissions 37                         37            
Sale of common stock net of commissions, shares                   34,246                    
Issuance of common stock warrants 890                         890            
Accretion of noncontrolling interest put option to redemption value (80)                                   (80)  
Temporary Equity, Accretion of noncontrolling interest put option to redemption value               80                        
Foreign currency translation adjustment (466)                               (466)      
Temporary Equity, Foreign currency translation adjustment               (693)                        
Net loss (14,149)                                   (14,149)  
Balance at Sep. 30, 2022 $ (3,595)                 $ 7       $ 295,333     $ (810)   $ (298,125)  
Temporary Equity Balance at Sep. 30, 2022               $ 10,474                        
Temporary Equity Balance, shares at Sep. 30, 2022     0                                  
Balance, shares at Sep. 30, 2022                   72,983,488